Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma.

[1]  J. Bousquet,et al.  Eosinophilic inflammation in sputum of poorly controlled asthmatics , 2002, European Respiratory Journal.

[2]  R. Djukanović,et al.  Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation , 2002, European Respiratory Journal.

[3]  K. J. Macleod,et al.  Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. , 2002, The American journal of medicine.

[4]  M. Segal,et al.  Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. , 2001, The Journal of allergy and clinical immunology.

[5]  H. Simon.  Regulation of eosinophil and neutrophil apoptosis – similarities and differences , 2001, Immunological reviews.

[6]  R. Djukanović,et al.  The relationship between airways inflammation and asthma severity. , 2000, American journal of respiratory and critical care medicine.

[7]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[8]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[9]  K. Chung,et al.  Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. , 1999, American journal of respiratory and critical care medicine.

[10]  K. Ishihara,et al.  Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. , 1998, European journal of pharmacology.

[11]  T L Petty,et al.  Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. , 1998, The Journal of allergy and clinical immunology.

[12]  F. Saulnier,et al.  Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.

[13]  T. Hacken.  Airway inflammation in nocturnal asthma , 1998 .

[14]  S. Wenzel,et al.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.

[15]  P. Howarth,et al.  The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. , 1997, American journal of respiratory and critical care medicine.

[16]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[17]  A. J. Wilson,et al.  Eosinophil apoptosis and the resolution of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[18]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[19]  R. Dahl,et al.  Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. , 1996, American journal of respiratory and critical care medicine.

[20]  Y. Nakamura,et al.  Anti-inflammatory effects of inhaled beclomethasone dipropionate in nonatopic asthmatics. , 1996, The European respiratory journal.

[21]  A. James,et al.  Airway structure and inflammatory cells in fatal attacks of asthma. , 1996, The European respiratory journal.

[22]  W. Liles,et al.  Glucocorticoids inhibit apoptosis of human neutrophils. , 1995, Blood.

[23]  G. Cox,et al.  Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. , 1995, Journal of immunology.

[24]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[25]  G. Gleich,et al.  Sudden-onset fatal asthma. , 1994, Mayo Clinic proceedings.

[26]  C E Reed,et al.  Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? , 1993, The American review of respiratory disease.

[27]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[28]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[29]  R. Ballard,et al.  Airways inflammation in nocturnal asthma. , 1991, The American review of respiratory disease.

[30]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[31]  T. Wagner,et al.  First-time treatment with steroids in bronchial asthma: comparison of the effects of inhaled beclomethasone and of oral prednisone on airway function, bronchial reactivity and hypothalamic-pituitary-adrenal axis. , 1990, The European respiratory journal.

[32]  C. Jenkins,et al.  Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. , 1988, Thorax.

[33]  H. Boushey,et al.  O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. , 1986, Journal of applied physiology.

[34]  P. O'Byrne,et al.  Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. , 1984, The American review of respiratory disease.